Lobbying registration dated 2026-03-30
Registrant: Karen Heim
Client: Alexion Pharma Canada
Targeted institutions:
Treasury Board Of Canada Secretariat (TBS)
Prime Minister's Office (PMO)
Innovation, Science and Economic Development Canada (ISED)
Global Affairs Canada (GAC)
Patented Medicine Prices Review Board (PMPRB)
Privy Council Office (PCO)
Health Canada (HC)
Government funding received:
Lobbying activity details:
Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board.
Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s Biomanufacturing and Life Sciences Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals including any health technology assessment-related or other policy discussions that might involve Health Canada and its ongoing relationship with Canada's Drug Agency and/or other pan-Canadian health organizations.
Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, specifically aspects related to the pharmaceutical and life sciences sector, including intellectual property protection and attraction of investments in research and development.